[go: up one dir, main page]

FI842400L - Naproxen- och naproxen-natriumtabletter, vilka frigoers kontrollerat. - Google Patents

Naproxen- och naproxen-natriumtabletter, vilka frigoers kontrollerat. Download PDF

Info

Publication number
FI842400L
FI842400L FI842400A FI842400A FI842400L FI 842400 L FI842400 L FI 842400L FI 842400 A FI842400 A FI 842400A FI 842400 A FI842400 A FI 842400A FI 842400 L FI842400 L FI 842400L
Authority
FI
Finland
Prior art keywords
naproxen
frigoers
vilka
och
controllers
Prior art date
Application number
FI842400A
Other languages
English (en)
Other versions
FI83037B (fi
FI83037C (fi
FI842400A0 (fi
Inventor
Charles S Hsiao
John S Kent
Original Assignee
Syntex Pharma Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24004892&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI842400(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Syntex Pharma Int filed Critical Syntex Pharma Int
Publication of FI842400A0 publication Critical patent/FI842400A0/fi
Publication of FI842400L publication Critical patent/FI842400L/fi
Publication of FI83037B publication Critical patent/FI83037B/fi
Application granted granted Critical
Publication of FI83037C publication Critical patent/FI83037C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
FI842400A 1983-06-14 1984-06-13 Foerfarande foer framstaellning av en naproxen och natrium naproxentablett med styrd utloesning. FI83037C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/504,112 US4571333A (en) 1983-06-14 1983-06-14 Controlled release naproxen and naproxen sodium tablets
US50411283 1983-06-14

Publications (4)

Publication Number Publication Date
FI842400A0 FI842400A0 (fi) 1984-06-13
FI842400L true FI842400L (fi) 1984-12-15
FI83037B FI83037B (fi) 1991-02-15
FI83037C FI83037C (fi) 1991-05-27

Family

ID=24004892

Family Applications (1)

Application Number Title Priority Date Filing Date
FI842400A FI83037C (fi) 1983-06-14 1984-06-13 Foerfarande foer framstaellning av en naproxen och natrium naproxentablett med styrd utloesning.

Country Status (24)

Country Link
US (2) US4571333A (fi)
AT (1) AT389225B (fi)
AU (1) AU552080B2 (fi)
BE (1) BE899885A (fi)
CA (1) CA1204671A (fi)
CH (1) CH643455A5 (fi)
DE (1) DE3329265A1 (fi)
DK (1) DK162814C (fi)
FI (1) FI83037C (fi)
FR (1) FR2547498B1 (fi)
GB (1) GB2141338B (fi)
HK (1) HK95590A (fi)
IE (1) IE55585B1 (fi)
IL (1) IL69371A0 (fi)
IT (1) IT1200967B (fi)
LU (1) LU84962A1 (fi)
MY (1) MY100439A (fi)
NL (1) NL191669C (fi)
NO (1) NO167001C (fi)
NZ (1) NZ204708A (fi)
PH (1) PH17827A (fi)
SE (1) SE454565B (fi)
SG (1) SG80990G (fi)
ZA (1) ZA835591B (fi)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4061897A (en) * 1976-01-23 1977-12-06 Audrae Thykeson Heating pad
US4571333A (en) * 1983-06-14 1986-02-18 Syntex (U.S.A.) Inc. Controlled release naproxen and naproxen sodium tablets
US4695591A (en) * 1985-03-29 1987-09-22 Schering Corporation Controlled release dosage forms comprising hydroxypropylmethylcellulose
US4734285A (en) * 1985-10-28 1988-03-29 The Dow Chemical Company Sustained release compositions
US5527545A (en) * 1989-09-18 1996-06-18 Recordati S.A. Chemical And Pharmaceutical Company Liquid-suspension controlled-release pharmaceutical composition
IT1256651B (it) * 1992-12-11 1995-12-12 Giancarlo Santus Composizione farmaceutica a rilascio controllato in sospensione liquida
IE66933B1 (en) * 1990-01-15 1996-02-07 Elan Corp Plc Controlled absorption naproxen formulation for once-daily administration
US5198227A (en) * 1990-01-22 1993-03-30 Mcneil-Ppc, Inc. Dual subcoated simulated capsule medicament
US5204116A (en) * 1991-05-01 1993-04-20 Alza Corporation Dosage form providing immediate therapy followed by prolonged therapy
US5225201A (en) * 1991-08-23 1993-07-06 Minnesota Mining And Manufacturing Company Salsalate tablet
DE4140172C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retardform für ein Ibuprofen enthaltendes Arzneimittel
DE4140185C2 (de) * 1991-12-05 1996-02-01 Alfatec Pharma Gmbh Ein 2-Arylpropionsäurederivat in Nanosolform enthaltendes Arzneimittel und seine Herstellung
DE4140183C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retardform für ein Flurbiprofen enthaltendes Arzneimittel
DE4140184C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Akutform für ein Flurbiprofen enthaltendes Arzneimittel
IL104192A (en) * 1992-02-17 1998-01-04 Siegfried Ag Pharma Pharmaceutical dosage forms having prolonged release rate of zero order of the active ingredient
EP0557244B1 (en) * 1992-02-17 1996-03-13 Siegfried Pharma AG Dosage forms having prolonged active-ingredient release
WO1993017673A1 (en) * 1992-03-03 1993-09-16 Top Gold Pty., Limited Sustained release analgesics
DE4226753A1 (de) * 1992-08-13 1994-02-17 Basf Ag Wirkstoffe enthaltende Zubereitungen in Form fester Teilchen
US5609884A (en) * 1992-08-31 1997-03-11 G. D. Searle & Co. Controlled release naproxen sodium plus naproxen combination tablet
DK0661045T3 (da) * 1992-09-18 2002-10-28 Yamanouchi Pharma Co Ltd Hydrogelpræparat med forsinket frigivelse
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US20060263428A1 (en) * 1993-09-20 2006-11-23 Eugenio Cefali Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US5484607A (en) * 1993-10-13 1996-01-16 Horacek; H. Joseph Extended release clonidine formulation
US6080888A (en) * 1997-01-08 2000-06-27 Albemarle Corporation Preparation of olefinic compounds and carboxylic derivatives thereof
US6096920A (en) * 1997-01-08 2000-08-01 Albemarle Corporation Preparation of carboxylic compounds and their derivatives
US5792886A (en) * 1997-01-08 1998-08-11 Albemarle Corporation Production of racemic 2-(6-methoxy-2-naphthyl) propionic acid of precursors thereof
US5874614A (en) * 1997-12-11 1999-02-23 Albemarle Corporation Sodium (S)-2-(6-methoxy-2-naphthyl)propionate monohydrate
US5859292A (en) * 1997-12-11 1999-01-12 Albemarle Corporation Preparation of high purity sodium (S)-2(6-methoxy-2-naphthyl)propionate
US7235258B1 (en) * 1999-10-19 2007-06-26 Nps Pharmaceuticals, Inc. Sustained-release formulations for treating CNS-mediated disorders
US6565868B1 (en) 2000-01-18 2003-05-20 Albemarle Corporation Methods for microbiological control in aqueous systems
US6508954B1 (en) 2000-01-18 2003-01-21 Albemarle Corporation 1,3-dibromo-5,5-dimethylhydantoin of enhanced properties
US20050049420A1 (en) * 2000-01-18 2005-03-03 Elnagar Hassan Y. Process for producing N-halogenated organic compounds
US7579018B2 (en) * 2000-01-18 2009-08-25 Albemarle Corporation Microbiological control in aqueous systems
US7371397B2 (en) * 2000-01-18 2008-05-13 Albemarle Corporation Methods for microbiological control in aqueous systems
US6448410B1 (en) 2000-01-18 2002-09-10 Albemarle Corporation Production of compacted biocidal agent from particulate biocidal agent without using a binder
US7999118B2 (en) 2000-01-18 2011-08-16 Albemarle Corporation Process for producing N-halogenated hydantoins
US6809205B1 (en) 2000-01-18 2004-10-26 Albemarle Corporation Process for producing N-halogenated organic compounds
US6680070B1 (en) 2000-01-18 2004-01-20 Albemarle Corporation Particulate blends and compacted products formed therefrom, and the preparation thereof
US6638959B2 (en) 2000-01-18 2003-10-28 Albemarle Corporation Microbiological control in aqueous systems
US6495698B1 (en) 2000-01-18 2002-12-17 Albemarle Corporation Binder-free compacted forms of 1,3-dihalo-5,5-dimethylhydantoins
US6908636B2 (en) * 2001-06-28 2005-06-21 Albermarle Corporation Microbiological control in poultry processing
WO2003011033A1 (en) * 2001-06-28 2003-02-13 Solution Biosciences, Inc. Microbiological control in animal processing
US6986910B2 (en) * 2001-06-28 2006-01-17 Albemarle Corporation Microbiological control in poultry processing
WO2003017981A1 (en) * 2001-08-29 2003-03-06 Ranbaxy Laboratories Limited Controlled release formulation of clarithromycin or tinidazol
EA200400343A1 (ru) * 2001-08-29 2004-08-26 Рэнбакси Лабораториз Лимитед Композиция с контролируемым высвобождением кларитромицина или тинидазола
EP1441988A1 (en) * 2001-10-09 2004-08-04 Albemarle Corporation Control of biofilms in industrial water systems
US6602911B2 (en) * 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
AU2003225837B2 (en) * 2002-03-15 2008-11-06 Forest Laboratories Holdings Limited NE and 5-HT reuptake inhibitors for treating visceral pain syndromes
US20040010024A1 (en) * 2002-07-10 2004-01-15 Howarth Jonathan N. Particulate blends and compacted products formed therefrom, and the preparation thereof
US6965035B1 (en) 2002-07-25 2005-11-15 Albemarle Corp Compacted forms of halogenated hydantoins
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040121010A1 (en) * 2002-10-25 2004-06-24 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040228918A1 (en) * 2003-01-02 2004-11-18 Chih-Ming Chen Granule modulating hydrogel system
EP1592453A1 (en) * 2003-01-28 2005-11-09 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
US20040185093A1 (en) * 2003-03-18 2004-09-23 Szymczak Christopher E. Compositions containing sucralose
US8158149B2 (en) * 2004-05-12 2012-04-17 Chelsea Therapeutics, Inc. Threo-DOPS controlled release formulation
WO2004100929A1 (en) 2003-05-12 2004-11-25 Synergia Pharma, Inc. Threo-dops controlled release formulation
US20040265445A1 (en) * 2003-06-24 2004-12-30 Liimatta Eric W. Microbiocidal control in the processing of poultry
US7901276B2 (en) * 2003-06-24 2011-03-08 Albemarle Corporation Microbiocidal control in the processing of meat-producing four-legged animals
US20040265446A1 (en) * 2003-06-24 2004-12-30 Mcnaughton James L. Microbiocidal control in the processing of poultry
US20070092566A1 (en) * 2003-08-04 2007-04-26 Ryouichi Hoshino Oral sustained-release tablet
US20060062811A1 (en) * 2004-09-21 2006-03-23 Szymczak Christopher E Medicinal cooling emulsions
EP2314165B1 (en) * 2004-12-23 2014-10-01 Albemarle Corporation Microbiocidal control in the processing of meat-producing four-legged animals
US7994220B2 (en) * 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
BRPI0620851B1 (pt) * 2005-12-01 2016-08-23 Albemarle Corp método para controle microbiano no processo de produção de carne de animais quadrúpedes
AU2008261957A1 (en) * 2007-06-08 2008-12-18 Addrenex Pharmaceuticals, Inc. Extended release formulation and method of treating adrenergic dysregulation
US20100172991A1 (en) * 2007-06-08 2010-07-08 Henry Joseph Horacek Extended Release Formulation and Methods of Treating Adrenergic Dysregulation
EP2590636A1 (en) 2010-07-06 2013-05-15 Grünenthal GmbH Novel gastro- retentive dosage forms comprising a gaba analog and an opioid
US9415048B2 (en) * 2010-07-08 2016-08-16 Wellesley Pharmaceuticals, Llc Pharmaceutical formulation for reducing frequency of urination and method of use thereof
US20120244218A1 (en) 2011-03-25 2012-09-27 Durkee Shane E Calcium supplement
CN106880614A (zh) * 2017-04-06 2017-06-23 地奥集团成都药业股份有限公司 一种萘普生缓释片及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3065143A (en) * 1960-04-19 1962-11-20 Richardson Merrell Inc Sustained release tablet
DE1228029C2 (de) * 1964-05-09 1973-05-17 Merck Ag E Verfahren zur Herstellung von Tabletten durch Pressen von Pulvergemischen ohne vorhergehende Granulation
US3870790A (en) * 1970-01-22 1975-03-11 Forest Laboratories Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose
FR2146564A5 (fi) * 1971-07-19 1973-03-02 Peugeot & Renault
GB1593261A (en) * 1976-07-23 1981-07-15 Inveresk Res Int Controlled release suppository
US4357469A (en) * 1979-06-14 1982-11-02 Forest Laboratories, Inc. Carrier base material for prolonged release therapeutic compositions
US4226849A (en) * 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
US4259314A (en) * 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals
DE3026402A1 (de) * 1980-07-11 1982-02-04 Syntex Corp., Palo Alto, Calif. Die verwendung analgetischer und nicht-hormonaler, entzuendungshemmender mittel bei der behandlung von mikrovaskulaeren erkrankungen
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4571333A (en) * 1983-06-14 1986-02-18 Syntex (U.S.A.) Inc. Controlled release naproxen and naproxen sodium tablets

Also Published As

Publication number Publication date
FI83037B (fi) 1991-02-15
FI83037C (fi) 1991-05-27
AU1801183A (en) 1984-12-20
AU552080B2 (en) 1986-05-22
SE454565B (sv) 1988-05-16
DK162814B (da) 1991-12-16
DK553683D0 (da) 1983-12-01
NZ204708A (en) 1984-12-14
NL191669C (nl) 1996-02-05
DE3329265C2 (fi) 1991-04-11
LU84962A1 (de) 1983-12-28
FR2547498B1 (fr) 1986-06-13
ATA191084A (de) 1989-04-15
NO167001C (no) 1991-09-25
DK162814C (da) 1992-05-04
FR2547498A1 (fr) 1984-12-21
FI842400A0 (fi) 1984-06-13
SE8304393D0 (sv) 1983-08-12
NL8302842A (nl) 1985-01-02
ZA835591B (en) 1985-03-27
US4803079A (en) 1989-02-07
NO842362L (no) 1984-12-17
AT389225B (de) 1989-11-10
MY100439A (en) 1990-09-29
NO167001B (no) 1991-06-17
BE899885A (fr) 1984-12-12
US4571333A (en) 1986-02-18
NL191669B (nl) 1995-10-02
DE3329265A1 (de) 1984-12-20
DK553683A (da) 1984-12-15
HK95590A (en) 1990-11-23
IT8367870A0 (it) 1983-08-12
SE8304393L (sv) 1984-12-15
GB2141338A (en) 1984-12-19
IL69371A0 (en) 1983-11-30
CA1204671A (en) 1986-05-20
SG80990G (en) 1990-11-23
CH643455A5 (de) 1984-06-15
IE831799L (en) 1984-12-14
GB2141338B (en) 1988-06-02
PH17827A (en) 1985-01-07
GB8321757D0 (en) 1983-09-14
IT1200967B (it) 1989-01-27
IE55585B1 (en) 1990-11-07

Similar Documents

Publication Publication Date Title
FI842400L (fi) Naproxen- och naproxen-natriumtabletter, vilka frigoers kontrollerat.
FI840594L (fi) Byggelement foer byggmodeller, isynnerhet foer leksaker.
FI840595L (fi) Byggelement foer byggmodeller, isynnerhet foer leksaker.
FI841067L (fi) Osynlig foerbindning av ytformiga delar, isynnerhet i moebler.
FI844472A0 (fi) Nmr-foerestaellningssystem, i vilket anvaends faeltkompensation.
FI840821L (fi) Mjuk, fuktresistant pappersprodukt.
FI844412A0 (fi) Omkopplarnaetdel, speciellt foer televisionsmottagare, vilken naetdel uppvisar en skyddskoppling foer begraensning av primaerstroemmen.
FI842803A0 (fi) Vridningselastisk, vibrationsdaempande axelkoppling.
FI852099A0 (fi) Vaermedyna, speciellt foer fordonssaeten.
FI852360L (fi) Torkningscylinder foer bandmaterialmaskin, isynnerhet pappersmaskin.
FI842986L (fi) Flytande, desinficerande stortvaettmedel.
FI834712A7 (fi) Vridfoerslutning foer smaelta raomaterial, speciellt metallsmaeltor.
ATE26702T1 (de) N,n-di-n-propyl-4-hydroxy-3methansulfonamidophenylethylamin.
FI840600A7 (fi) Aktiveringsledning foer supraledande anordningar, speciellt magneter.
FI841369L (fi) Ph-oberoende, kontrollerat frigoerande tablett.
FI843285A7 (fi) Foerfarande foer framstaellning av 16-fluoro-16,17-didehydro-prostanoider.
FI843965L (fi) Vaetskekyld kaernreaktor, speciellt kokvattenreaktor.
FI845029A0 (fi) Informationstavla, saerskilt foer vaegtrafikanter.
FI852394L (fi) Nypdon, speciellt klaednypa.
FI844328L (fi) Laos-nyckel-system, speciellt foer laosningsanordningar.
FI844499A0 (fi) Anordning foer stabilisering av en fraon en frekvensgenerator, speciellt en kvartsgenerator, avgiven frekvens.
FI842194A7 (fi) Anordning foer termisk fixering av textila ytmoenster, speciellt naet.
FI844393L (fi) Dammfria kinoxalin-1,4-di-n-oxider.
FI840176L (fi) Stoedhjulsenhet foer en hushaollsmaskin, saerskilt en tvaettmaskin.
FI842053A7 (fi) Foerfarande foer aostadkommande av en armerad murverksbalk, jaemte anordning foer genomfoerande av foerfarandet.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: SYNTEX PHARMACEUTICALS INTERNATIONAL